Given our discovery of higher PAR2 expression in both aging and adenine diet‐induced kidney injury models, and considering estrogen's known ability to mitigate inflammatory responses, further studies could explore whether estrogen could suppress PAR2 and PAR2‐related cellular senescence. The gene discussed is F2RL1; the disease is medical procedure.